E

Eton Pharmaceuticals
D

ETON

14.260
USD
-0.26
(-1.79%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
-79
حجم السوق
382,418,049
أصول ذات صلة
ABT
ABT
-0.770
(-0.56%)
135.620 USD
AMGN
AMGN
-2.10
(-0.70%)
295.22 USD
AZN
AZN
-0.575
(-0.77%)
74.425 USD
BMY
BMY
-0.910
(-1.80%)
49.760 USD
GSK
GSK
-1.630
(-3.84%)
40.840 USD
JNJ
JNJ
0.425
(0.27%)
157.090 USD
LLY
LLY
7.54
(0.93%)
819.54 USD
MRK
MRK
-0.050
(-0.06%)
81.740 USD
NVS
NVS
-1.255
(-1.04%)
119.495 USD
PFE
PFE
-0.315
(-1.27%)
24.535 USD
SNY
SNY
-1.170
(-2.30%)
49.680 USD
المزيد
الأخبار المقالات

العنوان: Eton Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.